Greater cortical gray matter density in lithium-treated patients with bipolar disorder

Biol Psychiatry. 2007 Jul 1;62(1):7-16. doi: 10.1016/j.biopsych.2006.10.027. Epub 2007 Jan 19.

Abstract

Background: The neurobiological underpinnings of bipolar disorder are not well understood. Previous neuroimaging findings have been inconsistent; however, new methods for three-dimensional (3-D) computational image analysis may better characterize neuroanatomic changes than standard volumetric measures.

Methods: We used high-resolution magnetic resonance imaging and cortical pattern matching methods to map gray matter differences in 28 adults with bipolar disorder, 70% of whom were lithium-treated (mean age = 36.1 +/- 10.5; 13 female subject), and 28 healthy control subjects (mean age = 35.9 +/- 8.5; 11 female subjects). Detailed spatial analyses of gray matter density (GMD) were conducted by measuring local proportions of gray matter at thousands of homologous cortical locations.

Results: Gray matter density was significantly greater in bipolar patients relative to control subjects in diffuse cortical regions. Greatest differences were found in bilateral cingulate and paralimbic cortices, brain regions critical for attentional, motivational, and emotional modulation. Secondary region of interest (ROI) analyses indicated significantly greater GMD in the right anterior cingulate among lithium-treated bipolar patients (n = 20) relative to those not taking lithium (n = 8).

Conclusions: These brain maps are consistent with previous voxel-based morphometry reports of greater GMD in portions of the anterior limbic network in bipolar patients and suggest neurotrophic effects of lithium as a possible etiology of these neuroanatomic differences.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Bipolar Disorder / diagnosis*
  • Bipolar Disorder / drug therapy*
  • Brain Mapping*
  • Brain-Derived Neurotrophic Factor / drug effects
  • Brain-Derived Neurotrophic Factor / physiology
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / pathology*
  • Female
  • Functional Laterality / physiology
  • Gyrus Cinguli / drug effects
  • Gyrus Cinguli / pathology
  • Humans
  • Hypertrophy / pathology
  • Image Processing, Computer-Assisted
  • Imaging, Three-Dimensional
  • Limbic System / drug effects
  • Limbic System / pathology
  • Lithium Compounds / pharmacology
  • Lithium Compounds / therapeutic use*
  • Magnetic Resonance Imaging
  • Male
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use

Substances

  • Brain-Derived Neurotrophic Factor
  • Lithium Compounds
  • Neuroprotective Agents